1. Blumenthal D, Tavenner M. The “meaningful use” regulation for electronic health records. N Engl J Med 2010;363:501-504.
[CROSSREF] [PUBMED]
2. Aaronson JW, Murphy-Cullen CL, Chop WM, Frey RD. Electronic medical records: the family practice resident perspective. Fam Med 2001;33:128-132.
[PUBMED]
3. Makoul G, Curry RH, Tang PC. The use of electronic medical records: communication patterns in outpatient encounters. J Am Med Inform Assoc 2001;8:610-615.
[CROSSREF] [PUBMED] [PMC] [PDF]
4. Chen C, Garrido T, Chock D, Okawa G, Liang L. The Kaiser Permanente Electronic Health Record: transforming and streamlining modalities of care. Health Aff (Millwood) 2009;28:323-333.
[CROSSREF] [PUBMED]
5. Christensen T, Grimsmo A. Expectations for the next generation of electronic patient records in primary care: a triangulated study. Inform Prim Care 2008;16:21-28.
[CROSSREF] [PUBMED]
6. Callen JL, Bevis M, McIntosh JH. Patients' perceptions of general practitioners using computers during the patient-doctor consultation. HIM J 2005;34:8-12.
[CROSSREF]
7. Yoon D, Park MY, Choi NK, Park BJ, Kim JH, Park RW. Detection of adverse drug reaction signals using an electronic health records database: Comparison of the Laboratory Extreme Abnormality Ratio (CLEAR) algorithm. Clin Pharmacol Ther 2012;91:467-474.
[CROSSREF] [PUBMED]
8. Park MY, Yoon D, Lee K, Kang SY, Park I, Lee SH, et al. A novel algorithm for detection of adverse drug reaction signals using a hospital electronic medical record database. Pharmacoepidemiol Drug Saf 2011;20:598-607.
[CROSSREF] [PUBMED]
9. Schneeweiss S. A basic study design for expedited safety signal evaluation based on electronic healthcare data. Pharmacoepidemiol Drug Saf 2010;19:858-868.
[CROSSREF]
10. Waller PC, Coulson RA, Wood SM. Regulatory pharmacovigilance in the United Kingdom: current principles and practice. Pharmacoepidemiol Drug Saf 1996;5:363-375.
[CROSSREF] [PUBMED]
11. Hauben M, Patadia V, Gerrits C, Walsh L, Reich L. Data mining in pharmacovigilance: the need for a balanced perspective. Drug Saf 2005;28:835-842.
[CROSSREF] [PUBMED]
12. Waller PC, Evans SJ. A model for the future conduct of pharmacovigilance. Pharmacoepidemiol Drug Saf 2003;12:17-29.
[CROSSREF]
13. Kim HS, Lee H, Park B, Park S, Kim H, Lee SH, et al. Comparative analysis of the efficacy of low- and moderate-intensity statins in Korea. Int J Clin Pharmacol Ther 2016;54:864-871.
[CROSSREF] [PUBMED]
14. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421.
[CROSSREF] [PUBMED]
15. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129:S1-S45.
[CROSSREF] [PUBMED]
16. Harrison JH Jr. Introduction to the mining of clinical data. Clin Lab Med 2008;28:1-7.
[CROSSREF] [PUBMED]
17. Choi IY, Park S, Park B, Chung BH, Kim CS, Lee HM, et al. Development of prostate cancer research database with the clinical data warehouse technology for direct linkage with electronic medical record system. Prostate Int 2013;1:59-64.
[CROSSREF] [PUBMED] [PMC]
18. de Mul M, Alons P, van der Velde P, Konings I, Bakker J, Hazelzet J. Development of a clinical data warehouse from an intensive care clinical information system. Comput Methods Programs Biomed 2012;105:22-30.
[CROSSREF] [PUBMED]
19. Lee YH, Bang H, Kim DJ. How to establish clinical prediction models. Endocrinol Metab (Seoul) 2016;31:38-44.
[CROSSREF] [PUBMED] [PMC]
20. Ryan RP, McManus RJ, Mant J, Macleod JA, Hobbs FD. Statins in heart failure: retrospective cohort study using routine primary care data. Ann Med 2009;41:490-496.
[CROSSREF] [PUBMED]
21. Cho Y, Choe E, Lee YH, Seo JW, Choi Y, Yun Y, et al. Risk of diabetes in patients treated with HMG-CoA reductase inhibitors. Metabolism 2015;64:482-488.
[CROSSREF] [PUBMED]
22. Marelli C, Gunnarsson C, Ross S, Haas S, Stroup DF, Cload P, et al. Statins and risk of cancer: a retrospective cohort analysis of 45,857 matched pairs from an electronic medical records database of 11 million adult Americans. J Am Coll Cardiol 2011;58:530-537.
[CROSSREF] [PUBMED]
23. Ohsfeldt RL, Gandhi SK, Fox KM, McKenney JM. Statin cost-effectiveness comparisons using real-world effectiveness data: formulary implications. Value Health 2008;11:1061-1069.
[CROSSREF] [PUBMED]
24. Kim HS, Lee SH, Kim H, Lee SH, Cho JH, Lee H, et al. Statin-related aminotransferase elevation according to baseline aminotransferases level in real practice in Korea. J Clin Pharm Ther 2016;41:266-272.
[CROSSREF] [PUBMED]
25. Jones PH, Nair R, Thakker KM. Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis. J Am Heart Assoc 2012;1:e001800
[CROSSREF] [PUBMED] [PMC]
26. Kim HS, Kim H, Lee H, Park B, Park S, Lee SH, et al. Analysis and comparison of statin prescription patterns and outcomes according to clinical department. J Clin Pharm Ther 2016;41:70-77.
[CROSSREF] [PUBMED]
27. Hippisley-Cox J, Pringle M, Cater R, Wynn A, Hammersley V, Coupland C, et al. The electronic patient record in primary care: regression or progression? A cross sectional study. BMJ 2003;326:1439-1443.
[CROSSREF]
28. El-Kareh R, Gandhi TK, Poon EG, Newmark LP, Ungar J, Lipsitz S, et al. Trends in primary care clinician perceptions of a new electronic health record. J Gen Intern Med 2009;24:464-468.
[CROSSREF] [PUBMED] [PMC] [PDF]